Simplex Trading’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,860
Closed -$9K 8554
2024
Q4
$9K Buy
1,860
+408
+28% +$6.97K ﹤0.01% 7241
2024
Q3
$39K Buy
1,452
+657
+83% +$20.4K ﹤0.01% 6099
2024
Q2
$32K Buy
795
+122
+18% +$6.71K ﹤0.01% 6498
2024
Q1
$44K Sell
673
-334
-33% -$24.9K ﹤0.01% 6368
2023
Q4
$114K Buy
1,007
+335
+50% +$35K ﹤0.01% 5247
2023
Q3
$122K Buy
672
+533
+383% +$140K ﹤0.01% 4888
2023
Q2
$50K Sell
139
-134
-49% -$60.5K ﹤0.01% 5834
2023
Q1
$181K Sell
273
-418
-60% -$371K ﹤0.01% 4444
2022
Q4
$605K Sell
691
-76
-10% -$95.6K ﹤0.01% 2974
2022
Q3
$841K Buy
767
+47
+7% +$62.1K ﹤0.01% 2854
2022
Q2
$596K Sell
720
-10
-1% -$10.3K ﹤0.01% 3226
2022
Q1
$1.13M Buy
730
+112
+18% +$151K ﹤0.01% 2766
2021
Q4
$1.11M Sell
618
-326
-35% -$872K ﹤0.01% 2724
2021
Q3
$3.86M Sell
944
-26
-3% -$90.9K ﹤0.01% 1434
2021
Q2
$4.26M Buy
970
+967
+32,233% +$3.82M ﹤0.01% 1329
2021
Q1
$1.69M Buy
+3
New +$16.9K ﹤0.01% 1811

Other funds holding BNGO

Simplex Trading's BNGO Position: Q1 2025 in Review

Simplex Trading sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 14 shares.

Simplex Trading first reported a position in BNGO in Q1 2021 and held it in 8 quarters. The position peaked at $2M in Q1 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • Simplex Trading reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 14 Bionano Genomics shares in Q1 2025.
  • Simplex Trading first reported a position in Bionano Genomics in Q1 2021 and held it in 8 quarters.
  • Simplex Trading's Bionano Genomics position peaked at $2M in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.